INTRODUCTION
A major application of pluripotent stem cells (PSCs) is their directed differentiation to diverse organ-specific cell types of interest. Much like normal development, this approach relies on stage-specific developmental signals that lead to sequential restriction of cell fate. For example, lung progenitors derived from PSCs arise via the primitive streak and definitive endoderm, then proceed via anterior foregut endoderm to a primordial lung progenitor, identified by the expression of the transcription factor Nkx2-1+ (Green et al., 2011; Huang et al., 2013; Longmire et al., 2012; Mou et al., 2012) . In general, this approach is useful not only as a model with the capacity to reveal cell fate decisions in high resolution and real time, but also for the generation of patient and tissue-specific cell types for disease modeling and drug screening.
Taken together, this unit describes an approach to generate primordial lung progenitors from pluripotent stem cells , purify these progenitors using a cell surface marker sorting strategy , and differentiate these cells further to epithelial-only airway spheres containing proximal lung epithelial cells, including secretory cells and lung basal cells. While these spheres do not contain ciliated cells, this lineage can be differentiated from these spheres using pharmacological Notch inhibition or after transfer to air-liquid interface culture . mTeSR1 defined feeder-free medium (StemCell Technologies, cat. no anti-C-Kit) Mouse IgG2a, PE conjugated (StemCell Technologies, cat. no. 60108PE) Anti-human CD184 (CXCR4), PE-conjugated (StemCell Technologies, cat. no. 60089PE) Ice Complete Serum Free Differentiation Medium (cSFDM, see recipe) 10 mM SB431542 (see recipe) 2 mM Dorsomorphin (see recipe) 3 mM CHIR99021 (see recipe) 10 µg/ml recombinant human BMP4 (rhBMP4; see recipe) 100 µM retinoic acid (see recipe) F-12
Sterile 12-or 6-well tissue culture plates Humidified 37°C incubator with 5% CO 2 1000-µl pipette Sterile 15-ml and 50-ml conical tubes Centrifuge Automated cell counting system (e.g., Luna Automated Cell Counter, Logos Biosystems) Light microscope 1.5-ml microcentrifuge tubes 5-ml serological pipettes Falcon round bottom polystyrene or polypropylene tubes (dependent on flow cytometer specifications) Flow cytometer: able to detect PE, APC, and AlexaFluor 488 fluorescence 
Differentiation to definitive endoderm
1. Expand PSCs on tissue culture plates using standard procedure.
Definitive endoderm induction requires 2 × 10 6 cells for each well of a 6-well plate of endoderm desired, which is equivalent to approximately one confluent well of a 6-well plate. Expansion of undifferentiated PSCs on mTeSR is highly recommended. Typically, the adaptation of a cell line from feeder culture to feeder-free can be accomplished in ß2 weeks; however, if cells must be maintained on an irradiated MEF feeder layer, many more cells (approximately 3 to 4 confluent wells of a 6-well plate per well of definitive endoderm) may be required. Maintenance of PSCs using other feeder-free methods (e.g., E8 or equivalent) has not been thoroughly tested or validated for differentiation in this protocol.

For cells maintained in mTeSR, one near-confluent well (ready to passage; Fig. 2) typically contains sufficient cell numbers to be replated at the appropriate density in 1 well of the same size for definitive endoderm differentiation. See Figure 2 for images of typical density of undifferentiated cells at day -1 and day 0.
2. Prepare as many wells of tissue culture plates (typically one 6-well plate) as desired for definitive endoderm induction by diluting one aliquot of ESC-qualified Matrigel in 25 ml DMEM (final concentration = 1 mg/ml), adding 1 ml/well of a 6-well plate, and allowing to gel for 30 to 60 min at 37°C.
Follow the manufacturer's directions for dividing into aliquots and subsequent dilution of ESC-qualified Matrigel, as this product exhibits lot-to-lot variability in protein concentration.
It is recommended to include an extra well of endoderm for evaluation of endoderm induction efficiency.
3. Aspirate medium from the cells, add 1 ml/well (for 6-well plates) Gentle Cell Dissociation Reagent (GCDR) and incubate for 8 to 10 min at 37°C.
The duration of GCDR treatment required for effective dissociation is highly variable from line-to-line and across experiments. When cells are ready to dissociate, the previously densely packed PSC colonies will become less well-formed and contain visible single cells.
4. Gently pipette up and down with a 1000-µl pipette to dissociate PSCs from the plate and transfer into a new 15-ml conical. Add an equivalent volume of warm DMEM to the cells to dilute the GCDR.
5. Centrifuge the cells for 5 min at 300 × g, 4°C.
6. Aspirate the medium from the cell pellet and resuspend in 1 ml mTeSR1 supplemented with 10 µM Y-27632. Remove a sample of cells (typically 10 µl) and combine with an equal volume for automated cell counting to determine total cell number. After cell counting, add additional mTeSR with Y-27632 to a final concentration of 1 × 10 6 cells/ml. 13. After cells are fully dissociated, gently pipette the cells up and down in the GCDR to generate a single-cell suspension and transfer into a new 15-ml conical tube. Add in an equivalent volume of empty medium (e.g., IMDM). Centrifuge the cells for 5 min at 300 × g, 4°C.
14. Resuspend the cells in 1 ml FACS buffer and perform a cell count. Transfer a volume containing 0.5 × 10 6 cells into each of five 1.5-ml microcentrifuge tubes and centrifuge the cells for 5 min at 300 × g, 4°C.
15. Resuspend each pellet in 100 µl FACS buffer. Label the tubes for each stain, indicated below, and add the appropriate antibodies:
Unstained: No antibody Isotypes: 2 µl mouse IgG1, APC conjugated; 2 µl mouse IgG2a, PE conjugated CD117 only: 2 µl anti-human CD117 CXCR4 only: 2 µl anti-human CXCR4 Double stain: 2 µl anti-human CD117; 2 µl anti-human CXCR4.
16. Gently pipette the cells up and down and place on ice in the dark for 30 min to stain.
17. After 30 min, add 1 ml FACS buffer to each tube and centrifuge the cells for 5 min at 300 × g, 4°C.
18. Resuspend each pellet in 500 µl FACS buffer. Evaluate staining using a compatible flow cytometer and standard protocols, including compensation, by gating first for cell size (FSC versus SSC) and subsequently for expression of CD117 and CXCR4. .
Replating cells to generate anterior foregut endoderm
19. Once cells have reached the definitive endoderm stage (typically day 3), prepare anterior foregut endoderm medium ("DS/SB") by adding 1 µl of 2 mM dorsomorphin and 1 µl of 10 mM SB431542 per 1 ml of cSFDM (final concentration: 2 µM dorsomorphin, 10 µM SB431542 20. Prepare as many wells of tissue culture plates as required for replating by diluting one aliquot of ESC-qualified Matrigel in 25 ml DMEM (final concentration = 1 mg/ml) and allowing to gel for 30 to 60 min at 37°C.
21. Aspirate the medium and wash with 1 ml/well DMEM/F-12.
22. Add 1 ml/well GCDR and incubate for 2 to 3 min at room temperature (25°C).
23. Aspirate GCDR and add 1 ml/well DS/SB + Y-27632. Pipette gently with a 1000-µl pipette or a 5-ml serological pipette to dislodge monolayer into large, uniformly sized clumps of ß10 to 20 cells. Transfer the cells into a new 15-or 50-ml conical tube of sufficient size to hold final volume and add DS/SB + Y-27632 to a final volume equivalent to 2 ml/well for the number of wells to be replated. Specification of NKX2-1+ lung progenitors 26. After anteriorization (typically 72 hr, or day 6 of total differentiation), prepare lung induction medium without RA ("CB") by adding 1 µl of 3 mM CHIR99021 and 1 µl of 10 µg/ml rhBMP4 per 1 ml of cSFDM (final concentration: 3 µM CHIR99021, 10 ng/ml rhBMP4). This medium can be stored up to 1 week at 4°C. McCauley et al., 2017) .
BASIC PROTOCOL 2
PURIFICATION OF NKX2-1+ LUNG PROGENITORS VIA CELL SORTING ON SURFACE PROTEINS CD47 AND CD26
This protocol describes an approach to enrich for NKX2-1+ cells derived in Basic Protocol 1 by flow cytometry-based cell sorting. Cells are harvested as a single-cell suspension, immunostained for CD47 and CD26, and sorted for cells expressing high levels of CD47 and low/no levels of CD26. These cells are relatively enriched for expression of NKX2-1 and can be further characterized or replated for downstream differentiation to airway epithelium. This protocol is applicable to cells derived using the approach described in this unit, and has not been further validated to enrich for NKX2-1 expression in lung progenitors derived from PSCs using other approaches. Sterile 12-or 6-well tissue culture plates Humidified 37°C incubator with 5% CO 2 Sterile 50-ml conical tubes 1000-µl or 5-ml pipettes 25-ml pipettes 40-µm strainer Centrifuge Automated cell counting system (e.g., Luna Automated Cell Counter, Logos Biosystems) Sterile 1.5-ml microcentrifuge tubes 5-ml Falcon round-bottom polystyrene or polypropylene tubes (dependent on cell sorter specifications) High-speed cell sorter (e.g., MoFlo) able to perform two-way cell sorting and detect and compensate PerCP/Cy5-5, calcein blue, and PE staining Additional reagents and equipment for Support Protocol 2 may be required to evaluate efficiency of NKX2-1 enrichment
Materials
Harvesting and dissociating cells for staining 1. Wash the specified cells with DMEM, 1 ml/well of a 6-well plate.
2. Aspirate the wash medium. Add 1 ml/well of a 6-well plate of 37°C 0.05% trypsin and place in incubator for 14 to 18 min. 3. Pipette up and down (gently-2 or 3 times) until cells are fully detached from the plate and transfer into a 50-ml conical.
It is critical to ensure that the majority of the dissociation of the cells at this
4. Wash the well with an additional 1 ml of 0.05% trypsin. Add this wash to the conical tube and pipette up and down 1 to 2 additional times with a 1000-µl or 5-ml pipette to further dissociate the cell clusters. If many large clumps persist, manually shake, flick, and roll the 50-ml conical for 3 to 5 min. 5. Prepare "stop medium" by adding 50 ml FBS to 450 ml of DMEM. Add an equivalent volume of stop medium to the cell suspension and pipette up and down gently with a 25-ml pipette to mix the cell suspension.
For fewer wells of cells (with a consequent lower final volume of the cell suspension), a 5-to 10 ml pipette can be used instead.
6. Fit a 40-µm strainer to a new 50-ml conical tube and gently transfer the cell suspension into this new tube.
7. Centrifuge the cells for 5 min at 300 × g, 4°C.
8. Resuspend the cells in 1 ml FACS buffer and perform a cell count.
9. Centrifuge the cells for 5 min at 300 × g, 4°C, and resuspend the cell pellet in sort buffer at 100 µl per 1 × 10 6 cells. 11. Add 0.5 µl antibody per 100 µl staining volume to the appropriate conditions. 12. Place the samples on ice and stain the samples for 30 min, protected from light.
Sorting
13. While cells are staining, prepare collection tubes to capture sorted cells by adding a small volume of sort buffer into each collection tube. 14. After 30 min of staining, add 1 ml stop medium to each tube to remove excess antibody and centrifuge for 5 min at 300 × g, 4°C.
15. Aspirate the supernatant and resuspend the cell pellet in 500 µl of sort buffer per 1 × 10 6 cells.
Figure 4
Sorting algorithm for CD47 high , CD26 low lung progenitors. (A) Flow cytometry dot plots showing typical gating strategy for differentiations of variable efficiency. Cells were first be gated for size and granularity (FSC vs. SSC), then live cells (calcein blue+), then CD47 vs. CD26. As depicted, the lower limit of the CD47 high gate should be drawn just above where the CD26 + cloud intersects the main population. Following sorting, the indicated NKX2-1% enrichment was evaluated by intracellular NKX2-1 staining of aliquots of either bulk ("presort") or sorted (CD47high/CD26low; "post-sort") cells. (B) Typical appearance of controls, including isotypes, CD47 single-stain, CD26 single-stain, and CD47/CD26 double staining after appropriate pre-gating (SSC/FSS/Calcein blue) and compensation (using single color stained controls) for bleed through of the CD26-PE fluorescence into the channel measuring CD47-PerCP-Cy5 fluorescence. Note the expression of CD47 over isotype levels in nearly all cells.
16. Add 1 µl/ml of 10 µM calcein blue, AM (final concentration: 10 nM) to each of samples 2 to 6. 17. Transfer filtered cell suspension to appropriate round-bottom Falcon tubes for the sorting instrument and bring cells to sorter on ice, protected from the light.
18. Using a flow cytometer, and maintaining sterile conditions, sort CD47 high, CD26 low/negative cells into a collection tube (Fig. 4) . .
BASIC PROTOCOL 3
GENERATION AND PASSAGING OF AIRWAY EPITHELIAL ORGANOIDS
This protocol describes an approach to establish three-dimensional (3D) culture of purified PSC-derived lung progenitors generated in Basic Protocol 1 and Basic Protocol 2 and drive them towards an airway epithelial phenotype. After specification of the NKX2-1+ lung progenitor identity, withdrawal or inhibition of Wnt activity drives these epithelial lung progenitors towards a proximal airway fate, whereas continued Wnt activation drives distal differentiation . Therefore, this protocol relies on the expansion of specified, purified lung progenitors in "low-Wnt," FGF-containing media to drive differentiation or airway epithelial progenitors. Briefly, cells are resuspended in 3D Matrigel matrix and replated in tissue culture dishes. Culture of these cells in media driving activation of FGF signaling via FGF2 and FGF10 and containing corticosteroids and cyclic-AMP drives cells to form epithelial spheres containing differentiated airway cell types.
Materials
Cells (see Basic Protocol 2) Growth factor-reduced Matrigel matrix (Corning, cat. no. 356234) Airway Differentiation Medium (see recipe) 2 mg/ml dispase II (see recipe) 0.05% Trypsin-EDTA (e.g., Gibco, cat. no 25-300-062) Fetal bovine serum (FBS; e.g., Gibco, cat. no. 10082139) DMEM (Gibco, cat. no. 11995-065) Centrifuge 12-well sterile tissue culture plate 37°C incubator 1000-µl pipettes Sterile 15-ml conical tubes 6-well plates Figure 5 Phase-contrast microscopy and immunofluorescence microscopy of typical threedimensional culture at day 31 (airway organoid stage) after differentiation from single cells in airway differentiation medium from day 15-31. 3. Allow drops to solidify for 20 min at 37°C.
After drops have fully polymerized, add Airway Differentiation Medium carefully to wells.
Add enough medium to ensure that drops are fully covered, typically 1 to 2 ml per well of a 12-well plate.
5. Cells will begin to form epithelial spheres ("organoids") after several days to one week of culture and will continue to proliferate and expand until the drop is filled with cells (see Fig. 5 ). .
Passaging airway epithelial organoids 6. Aspirate medium and add 2 mg/ml dispase to the well to cover droplet (typically 1 ml/well) and incubate at 37°C for 30 min to 1 hr, until Matrigel is fully dissolved.
Dislodging the Matrigel pellet with a pipette prior to incubation and gentle pipetting 3 to 5 times after 10 min can facilitate dissociation.
7. Using a 1000-µl pipette, transfer dissociated organoids into a new 15-ml conical tube and add an equivalent volume of DMEM.
8. Centrifuge spheres for 1 to 2 min at 300 × g, 4°C.
If 9. Aspirate the supernatant and add 1 to 2 ml 0.05% trypsin per dissociated drop.
For example, if three drops were originally dissociated, add 3 ml trypsin.
10. Transfer trypsin and cells into a well of a 6-well plate and incubate for 8 to 10 min at 37°C. 11. While cells are dissociating, prepare "stop medium" by adding 50 ml FBS to 450 ml DMEM.
12. Collect dissociated cells in a new 15-ml conical tube and add an equivalent volume of stop medium.
13. Centrifuge the cells for 5 min at 300 × g, 4°C.
14. Resuspend the cells in 1 ml DMEM and count using an automated cell counter.
15. Centrifuge the cells and resuspend at a concentration of 1000 cells/µl in undiluted Matrigel matrix and replate in 50 to 100 µl drops, allow drops to solidify for 30 min to 1 hr at 37°C, and add Airway Differentiation Medium carefully to wells. 4. Aspirate PBS and add 1 ml/well of 0.3% Triton-X 100 for 10 min at 25°C to permeabilize cells. Wash the cells three times, for 3 min each time with 2 ml per well PBS.
Prepare blocking solution by diluting normal donkey serum (NDS) in PBS to a final concentration of 4% (v/v)
. Aspirate PBS and add 1 ml/well of 4% NDS. Incubate cells for 1 hr at room temperature.
For example, add 400 µl of NDS to 9.6 ml of PBS.
Other blocking reagents, such as 1% BSA, can also be used in lieu of 4% normal donkey serum.
Figure 6
Immunofluorescence microscopy for NKX2-1 (magenta) and DAPI (grey) at day 15 showing typical staining pattern for (A) high and (B) low-efficiency differentiations.
6. Prepare solutions of NKX2-1 antibody in 4% NDS, in 1. 8. Wash thee cells three times, for 3 min each time with 2 ml per well PBS.
9. Prepare dilute secondary antibody solutions in 1.5-ml microcentrifuge tubes and add the appropriate secondary antibodies to each well:
Unstained: No secondary antibody Secondary only: 1 µl donkey anti-rabbit (AlexaFluor 488 conjugated) in 500 µl PBS NKX2-1: 1 µl donkey anti-rabbit (AlexaFluor 488 conjugated) in 500 µl PBS.
10. Incubate with appropriate secondary antibody at room temperature for 30 min in the dark. After staining, wash three times, for 3 min each time with 2 ml per well PBS.
11. Counterstain with Hoechst (diluted 1:500 in PBS) for 30 min at room temperature in the dark.
12. Wash three times, for 3 min each time with 2 ml per well PBS.
13. Image the cells on a compatible fluorescence microscope for Hoechst (blue) and NKX2-1 (AlexaFluor 488 labeled) nuclear staining. Nuclear staining efficiency can be quantified by standard image analysis software (e.g., ImageJ). Figure 6 .
Typical Day 15 NKX2-1 immunofluorescence is shown in
SUPPORT PROTOCOL 2
FLOW CYTOMETRY FOR INTRACELLULAR NKX2-1
This protocol describes an approach to evaluate the efficiency of differentiation of lung progenitors using Basic Protocol 1 and the enrichment of these cells by cell sorting in Basic Protocol 2. For this latter application, an aliquot of cells should be taken after sorting based on CD47/CD26 gating for evaluation of NKX2-1 enrichment.
This approach relies on the fixation, permeabilization, and intranuclear staining of cells for NKX2-1 protein before evaluation by flow cytometry. 3. Filter cells through a 40-µm cell strainer into a new 50-ml conical and centrifuge for 5 min at 300 × g, 4°C.
Additional Materials (also see Basic Protocols 1 and 2)
4. Resuspend the cells in 1 ml FACS buffer and count using an automated cell counter. Centrifuge for 5 min at 300 × g, 4°C. 7. Centrifuge the cells for 5 min at 300 × g, 4°C, and resuspend in 100 µl staining buffer per 1 × 10 5 -1 × 10 6 cells for a total volume of at least 300 µl. Transfer 100 µl of cells to each of three 1.5-ml microcentrifuge tubes. Add 900 µl to each tube (final volume: 1 ml), incubate for 5 min at room temperature, and centrifuge the cells for 5 min at 300 × g, 4°C. 
REAGENTS AND SOLUTIONS
Use deionized, distilled water in all steps (unless otherwise noted).
Airway differentiation medium
45 ml cSFDM base (see recipe) 5 ml of 10× cyclic AMP/IBMX stock (see recipe) 50 µl of 250 µg/ml rhFGF2 
Complete serum-free differentiation medium (cSFDM)
Dexamethasone, 100 µM
Prepare 1 mM stock:
Dexamethasone powder (Sigma, cat. no. D4902-25MG) 63.7 ml molecular biology grade ethanol Store up to 2 years at −20°C Prepare 100 µM stock (working concentration): 500 µl of 1 mM dexamethasone stock 49.5 ml molecular biology grade ethanol Divide into 500-µl aliquots Store up to 1 year at −20°C Dispase II, 2 mg/ml 100 mg Dispase II, powder (ThermoFisher, cat no. 17105041) 50 ml DMEM Dissolve and filter sterilize using a 40-µm filter Store up to 2 weeks at 4°C or divide into 5-ml aliquots and freeze up to 6 months at −20°C
Dorsomorphin (DS), 2 mM
2 mg Dorsomorphin (Stemgent, cat. no. 04-0024) 2 ml dimethyl sulfoxide (DMSO) Filter sterilize using a 40-µm filter Divide into 50-µl aliquots Store up to 1 year at −20°C
After thawing individual aliquots, store up to 1 week at 4°C.
FACS buffer
49.5 ml of 1× phosphate-buffered saline 0.5 ml fetal bovine serum (e.g., Gibco, cat. no. 10082139) Store up to 2 weeks at 4°C Filter sterilize using a 40-µm filter Divide into 50-µl aliquots Store up to 1 year at −80°C
Retinoic acid (RA), 100 µM
Prepare 5 mM stock solution: 50 mg retinoic acid (Sigma, cat. no. R2625-50MG) 33.24 ml dimethyl sulfoxide (DMSO) Divide into 1-ml aliquots Store up to 1 year at −80°C ( kept away from light) Prepare 100 µM working solution: 1 ml of 5 mM stock solution. 49 ml molecular biology grade ethanol Store up to 1 month at −20°C (kept away from light)
Recombinant human FGF10, 10 µg/ml 25 µg recombinant human FGF10 protein (R&D Systems, cat. no. 345-FG-025) 2.5 ml of 0.1% bovine serum albumin (BSA)
Prepare 0.1% BSA in PBS by diluting 13 µl Bovine Albumin Fraction V, 7.5% solution in 1 ml PBS.
Filter sterilize using a 40-µm filter Divide into 500-µl aliquots Store up to 1 year at −80°C
SB431542 (SB), 10 mM
10 mg SB431542 (Tocris, cat. no. 1614) 2.6 ml dimethyl sulfoxide (DMSO) Filter sterilize using a 40-µm filter Divide into 50-µl aliquots Store up to 1 year at −20°C After thawing individual aliquots, store up to 1 week at 4°C
Sort buffer
50 ml FACS buffer (see recipe) 50 µl of 10 mM Y-27632 (see recipe) Store up to 2 weeks at 4°C
Y-27632 (Y), 10 mM
10 mg Y-27632 dihydrochloride (Tocris, cat. no. 1254) 3.1 ml sterile, tissue-culture grade water Filter sterilize (e.g., with EMD Millipore Sterile Disposable Vacuum Filter Units, cat. no. SCGP00525) Divide into 100-µl-aliquots Store up to 1 year at −80°C After thawing individual aliquots, store up to 1 month at 4°C
COMMENTARY Background Information
This procedure builds on years of careful work developing directed differentiation approaches for early and later stages of early lung development, from definitive endoderm to lung specification. Initially, methods were generated to derive definitive endoderm from both mouse and human PSCs, mainly via the activation of nodal signaling and consequent gastrulation and formation of the anterior primitive streak via high-dose Activin A (D' Amour et al., 2005; Kubo, 2004) . Additional studies using Bry and Foxa2 reporters have revealed that BMP, Wnt, and nodal signaling are required for and drive the formation of the primitive streak from PSCs (D'Amour et al., 2005; Gadue, Huber, Paddison, & Keller, 2006; Loh et al., 2014) . However, continued activation of BMP and Wnt after establishment of the primitive streak result in generation of a more posterior identity, resulting in emergence of mesodermal fate at the expense of definitive endoderm (Loh et al., 2014) .
PSC-derived definitive endoderm expresses early endodermal lineage markers (e.g., Foxa2, Sox17), differentiates to multiple endodermal lineages after transplantation in the mouse kidney capsule (D'Amour et al., 2005; Kubo, 2004) and can be driven in vitro with further patterning to more differentiated endodermal lineages, such as hepatocytes (GouonEvans et al., 2006) . These PSC-derived endodermal progenitors can also be patterned, much like the in vivo early endoderm, to subsets of foregut cells. Relevant to the goal of differentiating lung lineages is the ability to drive the expression of anterior foregut markers via the dual inhibition of BMP and TGFβ signaling (Green et al., 2011) . When derived from either mouse or human PSCs, these anterior foregut cells are then able to respond to FGF2 and BMP signaling to differentiate to Nkx2-1+Pax8+ thyroid progenitors (Kurmann et al., 2015; Longmire et al., 2012) or to combinatorial Wnt, retinoic acid, and BMP signaling to differentiate to Nkx2-1+Pax8-lung progenitors (Huang et al., 2013; Longmire et al., 2012; Rankin et al., 2016) . Recent work has characterized these NKX2-1+ lung progenitors in detail and demonstrated that they can differentiate to SFTPC+ distal lung epithelium in response to trophic stimulation by defined factors (e.g., CHIR99021, FGF10, KGF, steroids) or co-culture with mouse lung mesenchyme (Bilodeau, Shojaie, Ackerley, Post, & Rossant, 2014; Hawkins et al., 2017; Huang et al., 2013) . More recently, the robust differentiation of these progenitors to functional alveolar type II pneumocytes has been described . The reproducibility across human PSC lines, relative efficiency, and thorough characterization of this method to generate lung endoderm is the central advantage of the approach described here.
As directed differentiation can be inefficient and heterogeneous, the engineering of reporter cell lines allowing for live-cell sorting of populations of interest is critical to the study of cell fate decisions during directed differentiation. For example, our lab has previously published the use of reporter lines (e.g., carrying GFP targeted to the Nkx2-1 locus) for assessing the efficiency of endodermal lung or thyroid lineage specification in mouse (Longmire et al., 2012) or human PSCs . These reporter lines can be generated via a number of gene engineering approaches to introduce both a DNA double-strand break and repair template containing the reporter sequence targeted to a gene locus of interest.
In the absence of reporter lines, cell surface markers can be used as a surrogate to enrich for the population of interest. To identify PSCderived NKX2-1+ lung epithelial progenitors, two reliable cell surface markers, CPM and CD47, have recently been described (Gotoh et al., 2014; Hawkins et al., 2017) .
Finally, the efficient differentiation of purified NKX2-1+ lung progenitors to mature airway epithelial lineages has only recently been described (Konishi et al., 2016; McCauley et al., 2017) . The approach described in this protocol builds on the concept of directed differentiation of early progenitors to a defined population subset (e.g., proximal airway epithelium) by manipulation of developmentally-relevant signaling pathways. In this case, the protocol described here represents a method using three-dimensional culture of purified cells in conditions with lowto-no canonical Wnt signaling to drive the formation of airway epithelial spheres. These spheres are "epithelial-only" and contain lung secretory and basal epithelial cells, but no multiciliated cells unless a Notch inhibitor is added (likely due to high levels of Notch signaling as shown in McCauley et al., 2017) . While their epithelial-only composition makes these spheres amenable to experiments studying airway epithelial cell biology, additional mesenchymal, vascular, and immune lineages would need to be added to this model in order to develop the multi-lineage models required for future recapitulation of the full complexity of in vivo airway structure and function.
Critical Parameters
Pluripotency of undifferentiated PSCs
Differentiation efficiency relies on the pluripotency and health of the undifferentiated PSCs prior to replating for definitive endoderm. PSCs should be maintained in standard culture. All cell lines used for differentiation should be evaluated for karyotypic stability, absence of mycoplasma contamination, and pluripotency using standard techniques. Furthermore, a pipette should be used to scrape and discard any undifferentiated contamination prior to passaging cells to initiate differentiation to ensure robust induction of definitive endoderm.
Line-to-line variability
Pluripotent human ESCs are well known to have variable in vitro differentiation potential across lines. In the directed differentiation protocol described here, for example, NKX2-1 specification efficiency across diverse PSC lines can vary from 5-95%. With this in mind, it is important to characterize the NKX2-1 specification efficiency of any new PSC line and optimize the parameters that can contribute to NKX2-1 efficiency. In particular, the timing and density of replating of definitive endoderm for anteriorization is a critical step in the efficiency of directed differentiation of PSCs to lung epithelium . In differentiating any new line, one should test the effect of various timings and densities of definitive endoderm on the downstream NKX2-1 induction efficiency; for example, by replating endoderm every 12 hr between 60 and 96 hr. This experiment can furthermore be a useful training exercise that serves to emphasize the importance of careful timing of the endodermal stage on downstream differentiation capacity. One should take care to ensure that the anteriorization duration (e.g., 72 hr) is maintained for each endoderm timepoint.
Negative controls
To accurately evaluate the efficiency of NKX2-1 specification and of later airway differentiation, it is critical to include appropriate negative controls for both immunofluorescence and flow cytometry analyses as well as for reverse transcriptase quantitative PCR (RT-qPCR) analysis. Although undifferentiated PSCs are a convenient negative control, it can be difficult to interpret staining patterns in these cells in comparison to differentiated cells. It can therefore be useful to differentiate cells to a non-lung lineage, such as hepatocytes, using standard published protocols. These cells can then be used as negative controls, in particular when one is learning the expected NKX2-1 staining patterns. Comparisons to positive control primary lung cells or tissues is also recommended, particularly when employing RT-qPCR analyses of PSCderived putative lung lineages.
Selection of CD47
high /CD26 low gate As most cells (both lung and non-lung) generated in the approach described in Basic Protocol 1 express CD47, the gate for CD47 high expression intersects the positive cloud. Enrichment of the NKX2-1+ population is directly dependent on the location of this gate, which is most effective the higher it is on the CD47 channel. Typically, it is recommended to position the lower limit of the gate for the CD47 high population just above where the CD26+ cloud intersects the CD47+ population. Figure 4 provides several representative examples of acceptable CD47 gating based on this strategy.
Evaluation of lung progenitor differentiation
This protocol emphasizes the use of NKX2-1 expression as a metric to measure the efficiency of differentiation to the early lung progenitor lineage. However, there are several additional criteria that must be met to satisfy the designation of a cell as a "lung progenitor." Other than NKX2-1, there are no additional validated markers for early lung progenitors, and indeed NKX2-1 itself is also expressed early in thyroid endoderm and in forebrain neuroectoderm. The ideal approach, therefore, is to rule out the presence of other non-lung NKX2-1+ lineages (thyroid and forebrain). Lung progenitors should be NKX2-1+PAX8-TG-(non-thyroid) and NKX2-1+OTX2-SIX3-(non-forebrain) . To exclude these lineages, expression of these recommended markers should be evaluated by immunofluorescence microscopy or RT-qPCR in Day 15 lung progenitors. Lung progenitors should also be evaluated for their downstream lung competence by differentiation to cell types expressing highly lung-specific markers including 1) SCGB3A2+ proximal airway epithelium or 2) surfactant protein-C (SFTPC+) distal lung epithelium Huang et al., 2013) .
Expression of other popular "lung" markers, such as P63, CFTR, mucins, keratins, FOXJ1, or SFTPB in isolation are not lung specific, and in the absence of co-expression of NKX2-1 or in the absence of direct derivation from NKX2-1+ precursors cannot be reliably interpreted as proof of lung lineage.
While the protocol in this unit has not been found to produce neural or thyroid contaminants McCauley et al., 2017) , it remains critical for researchers to evaluate the expression of these markers and the downstream competence of these progenitors when using this protocol for their research.
Evaluation of airway epithelial sphere differentiation
It is critical to evaluate the final, differentiated proximalized lung spheres to ensure their airway identity. For initial experiments, spheres should be evaluated at least two weeks post-sorting. At this stage, the majority of spheres should be comprised of epithelial (EPCAM+) cells with a distinct lumen and the majority of cells should express SOX2 . Approximately 40% to 90% of cells should maintain expression of NKX2-1, and these NKX2-1+ cells can be segregated into multiple subsets, such as: SCGB3A2+ secretory cells, and P63+ cells, a portion of which also co-expresses KRT5+ reminiscent of in vivo airway basal cells . The identity of NKX2-1 negative cells in these spheres and whether these cells arise from the outgrowth of rare NKX2-1 negative cells present in the day 15 sorted samples remains uncertain to date, and may represent contaminating nonlung endodermal lineages that persist at some level throughout our protocol. Expression of markers can be evaluated by immunofluorescence microscopy or by transcriptomic methods (e.g., RT-qPCR), although the former is preferred as it provides a per-cell metric of the population subsets. When evaluating the identity and differentiation of these airway epithelial spheres, it is important to keep in mind the approach and the goals of the experiment. For example, it may be relevant to characterize the expression pattern and population segregation of a gene of interest in a particular airway disease, such as CFTR for cystic fibrosis.
Troubleshooting
Low endoderm induction efficiency
Endoderm induction, as measured by both nuclear expression of FOXA2 and by coexpression of the cell surface markers CD117 and CXCR4, is typically extremely efficient (>90%) using the StemDiff Definitive Endoderm Kit (StemCell Technologies). In general, troubleshooting of inefficient endoderm induction is well-described in the kit protocol, and therefore will not be discussed in detail here. In brief, the most common cause is low pluripotency of starting cultures, which can be addressed by ensuring that the starting cells have less than 5% spontaneous differentiation by eye prior to passaging for differentiation (see Fig. 2 ). Low confluency of starting cultures post-passage for definitive endoderm induction can also contribute to poor induction efficiency.
One important consideration that is more specific to this particular protocol is that low endoderm efficiency may result from evaluating the induction too early in differentiation; while 72 hr is typically long enough for >90% of cells to be CD117 and CXCR4 doublepositive, some lines may require longer differentiation time before one observes efficient endoderm induction by this metric.
Poor cell survival after endoderm replating
Cell survival post-passaging after endoderm differentiation (typically Day 3) can be a critical barrier to the success of this protocol. Low cell survival typically indicates that the cells were either dissociated into toosmall clumps, typically by excessive pipetting. One can improve cell survival by 1) using a cell scraper to dislodge cells from the confluent monolayer after dissociation by Gentle Cell Dissociation Reagent (StemCell Technologies), 2) pipetting cells as few times as possible (under 4 total is preferable) and 3) using a 5-ml pipette instead of a 1000-µl (or similar), to reduce shear forces. It can be useful to visualize the cells after replating to observe the initial size of the clumps, which should typically be between 15 to 20 cells in size. Clumps smaller than this, especially in more sensitive lines, may result in cell death during the anteriorization stage.
Low NKX2-1 induction efficiency
Other than cell survival, the most common challenge in this directed differentiation protocol is achieving consistent and efficient downstream induction of NKX2-1 expression. While substantial line-to-line variability (as well as some run-to-run variability within lines) is expected, consistent differentiations resulting in low-to-no differentiation of NKX2-1+ progenitors can result from several common factors:
First, as has been previously mentioned several times, efficient induction of definitive endoderm is required for effective downstream differentiation of lung progenitors. Furthermore, differentiation is additionally sensitive to the timing of definitive endoderm induction. Therefore, as has been previously recommended, a careful time kinetic of endoderm induction may improve downstream NKX2-1 efficiency .
The confluency of cells after replating from endoderm to anterior foregut endoderm (typically day 3) is also critical. If cultures are too confluent on Day 4, many lines can fail to generate appreciable numbers of NKX2-1+ progenitors during the subsequent lung induction stage. See Figure 2 for the typical appearance of cells on Day 4. To address this issue, one can either (1) test multiple replating densities to determine the optimal density for each line, or (2) passage cells using 0.05% Trypsin-EDTA on day 9 to 10 of differentiation at approximately a 1:3 split ratio.
Finally, as NKX2-1 induction relies on coordinated and time-sensitive signaling pathway activation or inhibition, it is important that growth factors are carefully diluted and aliquoted to ensure accurate concentrations of each stock, which should be stored at the recommended temperature and should not be kept beyond the recommended duration. As one additional point, it is important to keep track of the lot number of each stock of growth factors aliquoted, in case an issue should arise.
Low NKX2-1 enrichment from CD47 sorting NKX2-1 enrichment is contingent on a minimum threshold of initial differentiation. Differentiation efficiencies of less than 10% NKX2-1+ cells are not amenable to effective enrichment by CD47/CD26 sorting. If the differentiation efficiency is adequate, other possible explanations for low enrichment include inefficient staining. This can be evaluated by comparing the stained cells to the isotype. Almost all stained cells should be CD47+ (brighter staining) compared to the isotype antibody-stained control cells. See Figure 4 for typical staining patterns for various differentiation efficiencies.
One final possible explanation for low NKX2-1 enrichment is the selection of the CD47 gating parameters. Higher (more stringent) CD47 gating results in increased enrichment for NKX2-1 expression.
Low cell survival after sorting and replating
The most common explanation for low cell survival after sorting is high levels of cell death during dissociation, which stresses the surviving cells and extends the time required to sort an adequate population of live cells. To avoid this, cells should be dissociated primarily through enzymatic methods. The most common pitfall of this approach occurs when cells die after dissociation or sorting. The most common explanation for this cell death is overpipetting of cells during dissociation steps. A good guideline is that >65% of cells should fall within the size gate on FSC vs. SSC and, of these cells, >90% should be viable based on calcein blue or other viability staining (See Fig. 4) . Numbers lower than these, in particular increased levels of debris on the FSC vs. SSC dot plot, indicate excessive pipetting during dissociation.
Other potential explanations for low cell survival after sorting include the settings and nozzles used on the sorting instrumentation itself and the experience of the sorter and the investigator replating the cells, which can be remedied by open dialogue about the instrument parameters and continued practice with sorting and replating cells.
Anticipated Results
Using the described approach for directed differentiation, NKX2-1 induction efficiencies of 30% to 50% can be routinely expected from most PSC lines with some expected variability. For example, some lines routinely differentiate at >80% efficiency (e.g., BU3 Kurmann et al., 2015) ) and others more typically are <5% NKX2-1+ (e.g., H9 ESCs; also known as WA0-or NIH registry #0062). As discussed, this efficiency can be further optimized by careful design of experiments testing various differentiation parameters (e.g., cell density).
After sorting and replating in threedimensional culture, sphere formation should be efficient. By 2 weeks post-replating (e.g., total differentiation day 30), the majority of spheres are luminal, EPCAM+ and SOX2+. NKX2-1 expression is typically maintained in 40% to 90% of cells within these spheres. Differentiation to airway epithelial cell types including SCGB3A2+NKX2-1+ secretory cells and P63+KRT5+NKX2-1+ basal cells is easily detected by immunostaining. While this protocol does not reliably produce multiciliated cells, these cells can be generated within the spheres by either pharmacological inhibition of Notch signaling or by transfer of single-cell suspensions prepared from these spheres into 2D cultures on transwell inserts for expansion and differentiation at the air-liquid interface . Additionally, the relative ratios of the populations and the rate of emergence of these cell types (e.g., SCGB3A2+ airway progenitors vs. P63+KRT5+NKX2-1+ basal-like cells, etc.) is variable from run-to-run and should be routinely evaluated for each differentiation at the protein or transcriptome level, dependent on the experimental goals.
Experimental Design Considerations
The major important experimental design consideration, aside from the differentiation timing, is planning the number of wells of endoderm with which to begin the differentiation. As cells are passaged many times throughout the protocol, it is often possible to begin differentiation with just a single well of ß1 × 10 6 cells for definitive endoderm induction (plus one additional well to use to evaluate the definitive endoderm induction and end with many confluent wells by the end of lung specification (for example, 6 wells of approximately 3 × 10 6 cells each by day 15). The typical differentiation yield is approximately 4 to 18 NKX2-1+ progenitor cells on day 15 per input undifferentiated day 0 PSC. Therefore, to save time and resources, it is important to consider how many cells might be required for the final steps of the experiment and plan the number of wells of definitive endoderm accordingly.
Time considerations
Although this protocol in its entirety is lengthy (ß3 to 5 weeks), many days require only changing media. Therefore, it can be useful to plan the differentiation experiments around the key days of definitive endoderm induction (typically days -1 to 3), beginning lung specification (day 6), and harvesting lung progenitors for analysis or downstream applications (day 15). This lung progenitor timepoint can be varied around the day 15 timepoint. Typically, one should plan to harvest the lung progenitors sometime between day 14 and day 17. After sorting and replating, the cells can be harvested any time after they have recovered from sorting and formed distinct epithelial spheres, typically 1 to 2 weeks after sorting.
Related to this, planning an experiment can be challenging because it can be difficult to know when the undifferentiated cells will be ready to passage to begin differentiation. It is important to practice culturing and evaluating undifferentiated cell cultures to be able to anticipate the window when cells will be ready.
From a practical standpoint, the duration of sorting itself can vary depending on the experience of the investigator. With practice and the appropriate flow cytometer, an investigator can dissociate, sort on CD47 and CD26, and replate a 6-well plate of PSC-derived NKX2-1+ lung progenitors in ß3 hr.
